PATENT CLAIM ANALYSIS

Application Number: 15913248
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "230200"]

Abstract:
The present invention relates to an amorphous solid form of (4S)-7-(3,5-dimethylisoxazol-4-yl)-4-pyridin-2-yl-4,5-dihydroimidazo[1,5,4-de][1,4]benzoxazin-2(M)-one, and processes for its preparation, which is an inhibitor of BET proteins such as BRD2, BRD3, BRD4, and BRD-t and is useful in the treatment of various diseases such as cancer.

Claim (Index 55):
The method of  claim 54  wherein the organic solvent is methanol.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 90.0
- Lexical Diversity: 1.375
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15398907', '15906163', '14852958', '14923105', '14212721']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8053986604577612
- 35 USC 102 Novelty (BERT): 0.5537632219975522
- Combined Prediction Score: 0.7802351166117403
- Mean Citation Score: 444.1551040000001
- Max Citation Score: 457.70197
- Similarity Product: 247.49558677095413

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test